mannkind corp (MNKD:NASDAQ GM)
Transactions by MANNKIND CORP (MNKD) in the last 6 months
MannKind Corp. (NasdaqGM:MNKD) announced a private placement of its senior secured revolving promissory notes for gross proceeds of up to $175 million from new lender, Aventisub Inc., on September 23, 2014. The notes bear interest at a rate of 8.5% per annum and will be payable in-kind and compounded quarterly. The notes will be added to the outstanding principal balance under the loan facility. The lender will make one advance to the company in each calendar quarter ...
Sanofi-Aventis Deutschland GmbH entered into an agreement to acquire global rights of Afrezza from MannKind Corp. (NasdaqGM:MNKD) for approximately $930 million on August 11, 2014. Sanofi-Aventis will pay $150 million upfront and will pay up to $775 million as milestone payments. Sanofi will receive global licensing rights, rights for development and commercialization of Afrezza and will retain 65% of profits and losses with MannKind bearing 35% of the profits and losses. ...
|No competitor information is available for MNKD.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|